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Abstract
Background: Breast cancer is the second most common malignancy among women, next to
cervix cancer. Understanding its pathogenesis, morphological features and various risk-factors,
including family history holds a great promise for the treatment, early detection and prevention of
this cancer.
Patients and methods: In an attempt to evaluate the clinico-morphological patterns of breast
cancer patients, including their family history of breast and/or other cancers, a detailed analysis of
569 breast cancer cases diagnosed during the years 1989–2003 was carried out. Mean and standard
deviation and Odds ratios along with 95% confidence intervals were estimated. χ2/Fisher's exact
test were employed to test for proportions.
Results: Mean age of the patient at presentation was 47.8 years, ranging from 13–82 years. Among
the various histo-morphological types, Infiltrating duct carcinoma (IDC) was found to be
commonest type i.e. in 502 cases (88.2%), followed by infiltrating lobular carcinoma (ILC) in 21
cases (3.7%) and other types forming 9(1%). Out of 369 cases where TNM staging was available,
stage IIIB (35.2%) was the commonest. Lymph node positivity was observed in 296 cases (80.2%).
Out of 226 cases evaluated for presence of family history, 47 cases (20.7%) revealed positive family
history of cancer, among which breast or ovarian cancer were the commonest type (72.0%).
Patients below 45 years of age had more frequent occurrence of family history as compared to
above 45 years. Amongst familial cases, Infiltrating duct carcinoma was the commonest form
accounting for 68.8% cases while ILC was found to be in a higher proportion (12.5%) as compared
to non- familial cases (5.4%).
Conclusion: Among the various determining factors for development of breast cancer and for its
early detection, family history of cancer forms one of the major risk factor. It is important to take
an appropriate history for eliciting information pertaining to occurrence of cancers amongst the
patients' relatives there by identifying the high risk group. Educating the population about the risk
factors would be helpful in early detection of breast cancer.
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Background
Breast Cancer is the most frequent cancer in women
worldwide with 1.05 million new cases every year and
represents over 20% of all malignancies among females
[1]. Over 50% of breast cancer incidence occurs in the
developed world. High-risk areas include Europe and
North America. The lowest rates are reported from Africa
and Asia. However, it still ranks as the commonest cancer
among women in these regions. Incidence of breast cancer
is increasing in most of the countries, including the areas,
which have had previously low rates [2-4]. It is estimated
that in 2001 there were approximately 80,000 new breast
cancer cases in India [5]. The population based cancer reg-
istry data from the various parts of the country, has
revealed breast cancer as the commonest cancer among
women in Delhi, Mumbai, Ahmedabad, Calcutta and
Trivandrum. In the rest of the other Indian registries,
breast cancer is listed as the second leading site among
women [6,7]. The age standardized incidence rates vary
between 9–32 per 100,000 women. An increasing trend in
the incidence rates of the breast cancer has been reported
from the various registries of National Cancer Registry
Project [7]. This malignancy accounts for 19–34% of all
cancer cases among women nationally. While the epide-
miological studies for breast cancer carried out in India
have largely focused on risk factors such as, religion, age
at menarche, menopause and reproductive history, not
much attention has been paid on role of family history
even though genetic predisposition is responsible for 5–
10% of all breast cancers [8-17]. It is well known that the
hereditary factors play a far greater role in women for the
development of breast cancer [18-20]. Data so far availa-
ble is from the western studies. Several clinical and mor-
phological parameters such as histological type of tumor,
tumor grade, axillary lymph node involvement, bilateral-
ity etc. have been established as the predictors of tumor
behavior in breast cancer patients. These prognostic fac-
tors are indicators of the inherent aggressiveness of the
tumor as well as of the extent of the disease and based on
these factors, treatment decisions are being taken up by
the clinicians. The association of these prognostic factors
with familial cancers has not been documented.
The present study attempts to describe some of the clin-
ico-pathological features of the breast cancer cases seen at
a tertiary level hospital in the city of Delhi. The data has
been analyzed by various parameters such as age, religious
groups, morphological patterns of tumor, lymph node
status, TNM staging and a significant parameter lately
included i.e. familial history.
Patients and methods
A total of 788 specimens in the form of cytology and
biopsy, which were clinically diagnosed as breast cancer
cases were received at Institute of Pathology (IOP) during
the period 1989–2003. The following eligibility criteria
were employed for inclusion of cases into the study, (a)
patients with complete clinical details, containing the per-
sonal proforma (b) patients who were residents of India
and (c) histologically/cytologically confirmed cases of
breast cancer.
Of the 788 cases, 569 cases (72.2%) satisfied the eligibility
criteria and were included for the present analysis. The
detailed breakup regarding 218 ineligible cases was as fol-
lows: 104 were benign lesions on histopathological exam-
ination and 40 were inflammatory lesions. Eight cases
were of cystosarcoma phylloides. In 42 cases, the tissue
submitted was inadequate and in the rest 25 cases clinical
history was not available. For all those cases, which satis-
fied the eligibility criteria, clinical history and brief infor-
mation on socio demographic parameters viz. age,
religion, marital status and parity were extracted from the
clinical records. Information relating to bilaterality of the
cancer was recorded after the pathological diagnosis. Data
on family history of cancers were recorded up to second
degree after an in depth interview with the patient or with
the person accompanying the patient. A thorough rapport
was established before collecting the information regard-
ing the family history. Wherever possible, patients were
requested to bring the diagnostic reports relating to their
family members to confirm the authenticity of family his-
tory of cancer. Collection of information relating to the
family history was started only after 1998. The clinical
extent of the disease at presentation was assessed accord-
ing to the UICC TNM classification [21]. The religion wise
distribution of the population for the city of Delhi was
obtained from the reports of the latest census [22].
Clinical breast and axillary lymph node examination
In clinically selected cases, triple approach including clin-
ical examination coupled with ultrasonographic examina-
tion (USG) and mammography was also carried out. USG
was carried out to assess the extent of the axillary lymph
nodes more precisely. Axillary lymph node examination
was done clinically as well as by ultrasound. Most of the
patients of breast cancer that we receive are locally
advanced cancers and have palpable lymph nodes. As a
matter of policy, axillary clearance was thus done in most
patients. There was also a small percentage of patients
who did not have palpable lymph nodes,- for them axil-
lary lymph node sampling was done and if the level 1
lymph nodes were found to be positive, further manage-
ment was done.
Statistical analysis
The data were tabulated and analyzed. Mean and standard
deviation (SD) were computed for quantitative data. The
statistical significance of associations between the various
qualitative parameters was evaluated through Chi-squareWorld Journal of Surgical Oncology 2005, 3:67 http://www.wjso.com/content/3/1/67
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(χ2) test/Fisher's exact test (two tail). In view of skewness
in the age data the statistical significance of means was
tested through the non-parametric Mann Whitney test (in
case of two groups) or Kruscal Wallis one- way analysis of
variance for more than two groups. P value ≤ 0.05 was
considered statistically significant (S). Odds ratio (OR)
along with 95% confidence intervals (95% CI) were also
estimated, wherever applicable.
Results
Age
In the present series the average age of the patient at pres-
entation was 47.8 years with a standard deviation of 12.2
years. The youngest patient was 13 years and oldest
patient was 86 years old. The commonest age group of
incidence was 45–54 years (31.8%). Nearly 22% of cases
were below 40 years while 16% of cases were above the
age of 65 years.
Religion
Analysis of data by major religious groups indicated that
87%, 7.7% and 5.3% belonged to Hindus, Muslims and
Christian communities respectively. It may be noted that
while Christian population constituted only 0.88% of the
total population in the city of Delhi as per the reports of
latest census of 2001 the cancer cases in this community
accounted for 5.3%. The mean age at presentation accord-
ing to various religions was found to be 48.1 (SD =
12.28), 42.4 (SD = 9.15) and 50.8 (SD = 12.59) years for
Hindu, Muslim and Christians respectively. Christians
had higher age at presentation. The differences in the
mean age at presentation among different groups were
found to be statistically significant (P < 0.05).
Histo-morphological types
In the present study, various morphological variants and
patterns were observed. The histomorphological types
seen among 569 female breast cancers indicated that there
were 502 cases (88.2%) with histology of IDC not other-
wise specified (NOS), which was found to be the most
common type. This was followed in decreasing order by
infiltrating lobular carcinoma in 21 cases (3.7%); colloid
carcinoma in 6 cases (1.1%), ductal carcinoma-in-situ in
6 cases (1.1%), metaplastic type in 5 cases (0.9%), schir-
rous carcinoma in 5 cases (0.9%), apocrine type in 4 cases
(0.7%) and the rest 20 cases (3.5%) with other types of
carcinoma (Table 1).
Reproductive history
Out of 569 cases of breast cancer, it was observed that 6
cases (1.1%) were unmarried. Out of these, 3 were in the
age group 20–29 years and remaining 3 cases were in the
age group 30–39 years. Amongst the 563 married women,
four cases (0.7%) revealed a history of nulliparity. Out of
these 4 cases, 3 cases were in 40–49 years and remaining
one case was in the age group 50–59 years old.
Bilaterality
It was noted that out of 569 cases, 564 (99.1%) cases pre-
sented with unilateral breast lump that was proven to be
cancerous. Five cases presented with bilateral breast
lumps, subsequently proven to be cancerous. Out of
these, 2 were synchronous and 3 were metachronous.
Among the 5 bilateral cases, 3 cases revealed a positive
family history of cancer.
TNM staging
Of the 569 cases, TNM staging was available for 369
patients. The most commonly observed stage of
presentation was IIIB with 130 cases (35.2%) followed in
decreasing order of frequency by stages IIIA with 100 cases
(27.1%), IIB with 60 (16.3%) cases, IV with 29 cases
(7.9%) and stage I with only 5 cases (1.4%) (Table 2). Of
the 29 metastatic cases, 6 cases had supraclavicular lymph
nodes, 18 had hepatic and 5 cases had both hepatic and
skin deposits. The mean age of cases at presentation was
found to be 45.0 years (SD = 14.15) for cases in stage IIA
as compared to 51.1(SD = 13.67) years for cases in stage
IV. The mean age at presentation showed an increasing
trend for the various stages, viz – stage IIB (48.4 years, SD
= 10.69), IIIA (49.8 years, SD = 10.76), IIIB (50.6 years,
SD = 11.6) and was found to be statistically significant (p
< 0.05).
Lymph node status
Lymph node positivity was analysed histologically in all
the 369 cases. Histopathological confirmation of lymph
node involvement pN was observed in 296 cases (80.2%)
(Table 2). The mean age of cases with lymph node positiv-
Table 1: Distribution of cases according to histomorphological 
types
Histomorphological type No. %
Infiltrating duct carcinoma. [IDC] 502 88.2
Infiltrating lobular carcinoma. [ILC] 21 3.7
Colloid carcinoma. 6 1.1
Ductal carcinoma-in-situ 6 1.1
Metaplastic carcinoma. 5 0.9
Schirrous carcinoma. 5 0.9
Apocrine carcinoma. 4 0.7
Medullary carcinoma. 6 1.1
Tubular carcinoma. 3 0.5
Cribriform carcinoma. 3 0.5
Mixed ductal & lobular carcinoma. 5 0.9
Other carcinomas 3 0.5
Total 569 100
Others consisted of Epidermoid, Papillary and juvenile Secretory 
carcinomasWorld Journal of Surgical Oncology 2005, 3:67 http://www.wjso.com/content/3/1/67
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ity was found to be 48.5 (11.7) years as compared to 45.8
(SD = 13.43) years in negative cases. However, the differ-
ences were found to be statistically not significant
Association of religion with histo-pathological type, TNM 
staging and lymph node status
An analysis was carried out to understand, if any relation-
ship existed between the religious affiliation of patient
with histo-pathological type, TNM staging and lymph node
status as the cultural patterns are different in the three reli-
gions (Table 3). The three histo-pathological types of dis-
ease viz. IDC, ILC and "all other tumors combined
together" were considered for the above analysis. Percent-
age patients with these histopathological types were
found to be similar in all the three religious groups (p =
0.66). Percentage patients presenting with localized
tumors (TNM stage I & II) were found to be slightly higher
amongst Christians (39.1%) as compared to other two
religions (29.6% and 24.1%). However, the differences
were not found to be statistically significant amongst the
three religious groups (p = 0.84). Similarly, even the
lymph node involvement was also observed to be almost
similar in all the religious groups (p = 0.38).
Family history
Another important epidemiological parameter included
from the year 1998 was family history. The information
on family history was available for 226 cases. Out of these
226 cases, 47 cases (20.7%) revealed family history of can-
cer. Further, stratified analysis of data, by two broad
groups of less than or equal to 44 years and above 44 years
revealed that, of the 93 cases below the age group of 45
years, 27 (29.0%) women gave family history of cancer in
their first or/and second degree relatives. Similarly, in the
other age group of above 45 years, the frequency of cancer
was reported to be in 20 (15.0%) women of the 133
women belonging to above 45 years of age. The differ-
ences in the occurrence of cancer amongst the first and
second-degree relatives between the above two age groups
were found to be statistically significant (p < 0.05). In the
families of patients below 45 years a higher incidence of
cancer was noted as compared to patients above 45 years
of age. All women who had family history of breast cancer
in their families were considered as cases, while the rest of
women were taken as controls, for estimation of odd's
ratio in the age groups below and above 45 years. This was
found to be 2.3 (95% CI: 1.15–4.68, p < 0.02), indicating
more frequent occurrence of cancer in relatives of patients
below 45 years of age. Seventy two percent of cases (n =
34) with a positive family history revealed occurrence of
breast or ovarian cancers amongst their family members.
Remaining 28% of patients (n = 13) with a positive family
history reported other cancers in their relatives such as
lymphomas, thyroid cancer, prostate and colorectal carci-
nomas etc. Four patients (8.5%) gave the history of mul-
tiple cancers in their family members.
Table 2: Distribution of cases by stage, lymph node status and mean age.
Characteristics TNM grading No. Percentage Mean Age (SD)
TNM stage [N = 369]
Stage I T1N0M 5 1.4 N.C
Stage IIA 45 12.2 45.0(14.15)
T0N1M0 2
T1N1M0 5
T2N0M0 38
Stage IIB 60 16.3 48.4(10.69)
T2N1M0 37
T3N0M0 23
Stage IIIA 100 27.1 49.8(10.76)
T2N2M0 1
T3N1M0 67
T3N2M0 32
Stage IIIB 130 35.2 50.6(11.8)
T4 any NM0 126
Any T N3M0 4
Stage IV Any T any NM1 29 7.9 51.1(13.67)
Lymphnode status (N = 369)
Present 296 80.2 48.5(11.71)
Absent 73 19.8 45.8(13.43)
Percentages are against the total number of cases.
NC-Mean age (years) was not calculated due to small number of cases.World Journal of Surgical Oncology 2005, 3:67 http://www.wjso.com/content/3/1/67
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Further, an attempt was made to analyze the similarity in
the histo-pathological type of tumor between the familial
and non-familial groups of cases. It was observed that IDC
formed as the most common type of tumor in both
groups of cancer (68.8% and 75.5%). However, ILC was
present in a higher proportion in familial group (12.5%)
as compared to non-familial cases (5.4%). Further, "all
other tumors combined together" were found to be 18.7%
and 19.1% respectively. The differences, was not found to
be statistically significant possibly due to small number of
cases observed under the familial group (p > .10)
As regards the number of family members being affected
with the cancers, two patients (4.3%) revealed history of
cancer in more than 4 family members amongst their first
and/or second- degree relatives. Fifteen patients (31.9%)
had a history of cancer in two -three family members. Fur-
ther, thirty patients (63.8%) mentioned that there was
only one case of cancer amongst their relatives of first and
second degree. It was observed that on an average, 1.51
first and/or second degree family members had suffered
from cancer in these 47 families.
Discussion
Breast cancer incidence rates are increasing worldwide. In
India, it is the most common cancer among women in
many regions and has overtaken cervix cancer, which was
the commonest cancer a decade ago. The continuing rise
in breast cancer incidence has created an urgent need to
develop strategies for prevention. Breast cancer appears to
have a complex etiology, possibly with interplay of many
causal factors including hormonal, genetic and environ-
mental factors operating over a long period. Although sev-
eral risk factors have been well defined, the interactions of
the various etiological factors are yet to be completely
understood. Moreover, analysis of newer parameters like
family history could be helpful in screening high risk
women for developing breast cancer, followed by plan-
ning of future, preventive and treatment modalities.
Age of the cancer patient is an important factor both for
occurrence and management of the case. Average age of
the patients seen in the six hospital based cancer registries
in the National Cancer Registry Project (NCRP) network
for the period 1994–98 was found to range from 44.2
years in Dibrugarh to 49.6 years in Bangalore and Chen-
nai registries. In the present study the average age of the
breast cancer case at presentation was found to be 47.9
years. Our findings are in agreement with the findings of
the NCRP network [23]. Similarly, the average age of
breast cancer patients has been reported to be 50 to 53
years in various population-based registries located in dif-
ferent parts of the country [7]. Similar hospital based stud-
ies carried-out at Delhi and Jaipur have also reported that
the average age of breast cancer cases to be as 46.8 and 47
years [24,25]. The average age of occurrence of breast can-
cer amongst US white females has been reported to be
61.0 years [26]. The average age of occurrence of the breast
cancer in India reveals that the disease occurs a decade ear-
lier, as compared to western countries. The reason for
early age of occurrence amongst Indian females needs to
be further studied. A similar viewpoint has been put for-
ward by a study conducted by Borovanova [27] in the
Czech population. In their study, they found a shift of
cancer more towards younger women.
Epidemiological studies carried out in the country have
shown variation in the incidence of breast cancer among
different religious groups such as Hindus, Muslims, Chris-
tians, Parsi and Buddhists. Breast cancer incidence by reli-
gion for greater Bombay population indicated highest
incidence rates among Parsis and Christians and lowest
rates among Jains and Buddhists. In another study from
Chennai, the rates have been shown to be highest among
Christians followed by Hindus and Muslims. Similarly in
Trivandrum study, the incidence rates have been reported
to be highest among Christians followed by Hindus and
Muslims. Paymaster et al [14], in an analysis of hospital
cancer cases by major religious groups have shown the
variation in relative frequency between religious groups
and in particular, high percentage among Parsi women
compared to other religious communities. The reason for
high incidence of breast cancer in Parsi community is as a
result of their more westernized life-style, conserved
genetic pool, high frequency of consanguineous mar-
riages and higher age at the time of marriage and child
birth [28]. In our study, on comparison of relative fre-
quencies of cancer cases by various religious groups with
that of population distribution of Delhi by these religious
Table 3: Association of religion with histological type, TNM stage 
and lymph node status [Percentage distribution]
Characteristics/Religion Hindu Muslim Christian
Histological type [N = 569] %% %
IDC 88.7 84.1 86.7
ILC 3.2 6.8 6.7
Others 8.0 9.1 6.7
TNM stage [N = 369]
I 1.3 0.0 4.3
IIa 12.3 13.8 8.7
IIb 16.0 10.3 26.1
IIIa 27.4 24.1 26.1
IIIb 34.9 44.8 30.4
IV 8.2 6.8 4.3
Lymphnode status [N = 369]
Present 79.2 79.3 91.3
Absent 20.8 20.7 8.7
Percentages are against the total number of cases seen in each 
religion.World Journal of Surgical Oncology 2005, 3:67 http://www.wjso.com/content/3/1/67
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groups revealed that Christians had a higher percentage of
cancer. Although Christians accounted for only 0.88% in
the general population but relative frequency of cancer
cases in the present study were 5.8%. The other two reli-
gions had more or less similar proportions. Although, the
age at presentation amongst Christian patients was high-
est (51.5 years), as compared to other two religions, no
significant difference was noticed in stage at presentation
and lymph node status. The possible explanation for high
incidence and higher age at presentation amongst Chris-
tians may be the same as in Western population.
Few studies of international variation in breast cancer
have considered tumor histology. The histological type of
carcinoma whether it is invasive or an in situ type are fea-
tures which carry an inbuilt understanding of their general
behavior pattern. In a study conducted by Wynder et al
[4], comedo carcinoma and medullary carcinoma were
found to be more frequent in Tokyo. Cases from a broader
range of hospitals in Boston and Tokyo revealed occur-
rence of tumors of better prognostic types viz. intraductal,
medullary and colloid types in Tokyo than in Boston. It is
important to understand the relationship of histological
type to etiology, and to allow separation of entities with
distinct etiologies.
Histology as a prognostic factor has been well docu-
mented. Patients with histology of Infiltrating duct carci-
noma (IDC)(NOS) have a poor survival compared to
other types [17]. In the present study among the different
histomorphological types, Infiltrating duct Carcinoma
(NOS) was found to be the most common type i.e. in 502
cases (86.9%). The histological distribution of female
breast cancers seen during the years 1984–93 in the hos-
pital based cancer registries under the network of NCRP
revealed that, in Mumbai, Bangalore and Thiruvanan-
thapuram 83.3%, 85.0%, and 83.3% cases had a histology
of infiltrating duct carcinoma while, 2.7%, 1.7%, 1.6%,
belonged to lobular carcinoma, and the remaining 14.0%,
13.3%, 15.2% cases respectively were of other histopatho-
logical subtypes [23]. Infiltrating duct carcinoma was the
commonest type seen in our series. The findings of the
present study are almost in agreement with the findings
reported by the hospital based cancer registries under the
NCRP network. In the US population also, infiltrating
ductal type of breast carcinoma was found to be the com-
monest histological type [29]. Among the age-correlation
with various histomorphological types, prognostically
better tumours like juvenile secretory were more com-
monly observed amongst younger females while infiltrat-
ing ductal carcinoma and lobular carcinoma remained the
two most common cancers amongst elderly patients. It
was also noted that ILC was present in a higher proportion
in familial group (12.5%) as compared to non-familial
cases (5.4%) in the present study, however it was not
found statistically significant.
It is well known that breast cancer cases diagnosed at an
earlier stage have a more favorable prognosis compared to
those detected at late stage. However, because lack of
awareness, fear of disease and psychological reasons, most
of the patients in our country try to ignore or hide the dis-
ease and by the time they come to the hospital, the disease
is already in the late stages. In the present study, over 90%
of cases are in stages II, III and IV. The findings of the
present study reveal that breast cancer frequently presents
at higher stage i.e. 36.1% cases presenting with Stage IIIB
in Indian population. This reflects a need for awareness
and to initiate programs for early diagnosis of the cancer.
Numerous studies carried out in India and western popu-
lations have identified various reproductive factors
generally associated with breast cancer [9-11,13,29-31]. A
case-control study to identify risk factors for breast cancer
carried out in Mumbai, India indicated that single women
compared to married women had 4–5 fold higher risk for
development of breast cancer in the age group of 40–54
years and 55 and above [14]. In another study it has been
shown that nulliparous women had 2.2-fold higher risk
than parous women [16]. High incidence of breast cancer
among Parsi women was partly due to more unmarried
women, late age at marriage and first child, less children
and consanguinity of marriage [28]. Nulliparity and late
age at first birth are the consistently observed reproductive
risk factors [32]. In our study only 6 cases (1.0%) were
found to be unmarried and four married woman (0.6%)
were nulliparous.
Family history is another risk-factor for breast carcinoma.
It has been noted that women who have first degree rela-
tive with breast cancer have a risk two to three times that
of general population, the risk further increased if the rel-
ative was affected at an early age and/or had bilateral dis-
ease [20]. There is a greater risk if more than one close
relative is affected, if breast cancer has occurred at a young
age in a family member or if a patient has bilateral disease
[30]. One of the explanations for familial aspects of breast
cancer is germline mutation in BRCA1, BRCA2, p53 and
other genes [33]. These cellular genes, which comprise
dominantly acting oncogenes and recessively acting
tumour suppressor genes, have been shown to contribute
to genetic predisposition to variety of human cancers. In
the present study, 20.2% cases revealed a positive family
history of cancer. Out of these, higher percentages of cases
29.0% were observed in females under 44 years of age as
compared to 15% in women of above 45 years of age. The
presence of family history doubled the risk of subsequent
breast cancer among younger women. In a similar study
by Marcus et al, the relative risk of breast cancer was foundWorld Journal of Surgical Oncology 2005, 3:67 http://www.wjso.com/content/3/1/67
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to be doubled by the presence of a family history of breast
cancer and amplified by younger age. It has been stated
that there might be considerable underestimation of
hereditary breast cancers. The studies carried-out at Jaipur
and Delhi have reported the family history of cancer as
10% and 8% in their series. With documentation of pedi-
gree, familial breast cancer (FBCs) may constitute as high
as one third of the total incidence of breast cancers and
approximately one forth of them would fall into the sub-
set of hereditary breast cancer (HBC). It has been observed
that familial breast cancer patients have an improved rate
of survival, thereby indicating importance of noting famil-
ial cancer cases [33]. The present study clearly implies the
importance of taking an appropriate history for eliciting
family histories from the relatives. It is crucial to elicit
detailed personal and family history extending back to
atleast three generations, checking the medical records
including pathology reports, wherever possible it is better
to complete an accurate pedigree and taking family his-
tory from both maternal and paternal side of family. His-
tory of cancers among family members helps in
identifying high risk groups, who can be counselled and
subjected to careful follow ups with early diagnostic
modalities and can even choose certain therapies.
Improved ways of follow up with study of various inter-
acting genes would also be useful to identify high-risk
groups. Therefore, it is imperative to include parameters
like family history for better understanding of breast can-
cer causation and predisposition.
Breast cancer usually presents with a single hard lump as
is evident in the present study with occurrence of bilater-
ality in only 5 out of total 569 cases. In an earlier study,
bilaterality was reported in 3% of breast cancer patients
[34]. FBC have been observed to be having improved sur-
vival, as a result of stringent monitoring which may help
in diagnosis at early stage [30,35]. Clinical stage is another
factor implicated. In a study conducted by Langlands et al
[35], FBC cases had a lower stage of presentation. How-
ever, in our study, no such association was observed.
Conclusion
Continuing increased incidence of breast cancer has
added urgency to investigations of control and preventive
measures. It is important to incorporate primary and sec-
ondary prevention measures of breast cancer as number of
affected individuals is rising and the age of onset is shift-
ing towards younger age groups. Efforts should be made
to detect breast cancer at the very early stage through peri-
odic screening of high-risk groups either by physical self-
examination or by self-breast examination. Mammogra-
phy will be difficult to implement in Indian situation for
the control of breast cancer. Efforts should be made to
elicit information related to factors like family history of
breast cancer, thereby identifying high-risk groups. There
is a need to educate both high risk and all women about
the importance of Breast self Education (BSE) through
press and electronic media, thus more cases can be diag-
nosed at an early stage and effective treatment can be
given to those women and their lives can be saved.
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